Physiologic pacing of the His-Purkinje conduction system is feasible in patients who require a permanent pacemaker following TAVR and this alternative pacing method did not interfere with ejection ...
A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...
For patients with heart failure, a reduced ejection fraction, and an indication for cardiac resynchronization therapy (CRT), using His-Purkinje conduction system pacing (HPCSP) is safe and feasible ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
First-in-human report for UltiSynq CSP ICD lead ...
NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...
Abbott Laboratories (NYSE:ABT) released new late breaking clinical data on its advanced cardiac devices, focusing on pulsed ...
Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...
BOSTON -- Lead wires implanted for conduction system pacing have thus far been feasible to remove despite their more challenging characteristics, a multicenter study showed. The leads were removed ...
Conduction system pacing (CSP) produced the same degree of cardiac resynchronization, ventricular reverse modeling, and similar clinical outcomes as did biventricular pacing (BiVP) in patients with ...